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Herpes simplex virus (HSV) type-1 establishes lifelong latency in sensory neurones and it is widely
assumed that latency is the consequence of a failure to initiate virus immediate-early (IE) gene
expression. However, using a Cre reporter mouse system in conjunction with Cre-expressing
HSV-1 recombinants we have previously shown that activation of the IE ICP0 promoter can
precede latency establishment in at least 30% of latently infected cells. During productive
infection of non-neuronal cells, IE promoter activation is largely dependent on the transactivator
VP16 a late structural component of the virion. Of significance, VP16 has recently been shown to
exhibit altered regulation in neurones; where its de novo synthesis is necessary for IE gene
expression during both lytic infection and reactivation from latency. In the current study, we utilized
the Cre reporter mouse model system to characterize the full extent of viral promoter activity
compatible with cell survival and latency establishment. In contrast to the high frequency activation
of representative IE promoters prior to latency establishment, cell marking using a virus
recombinant expressing Cre under VP16 promoter control was very inefficient. Furthermore,
infection of neuronal cultures with VP16 mutants reveals a strong VP16 requirement for IE
promoter activity in non-neuronal cells, but not sensory neurones. We conclude that only IE
promoter activation can efficiently precede latency establishment and that this activation is likely to
occur through a VP16-independent mechanism.
INTRODUCTION
Primary infection with herpes simplex virus (HSV) results in
lifelong latency within sensory neurones followed by periodic
episodes of virus reactivation. During latency, the virus
genome is largely transcriptionally repressed and the only
viral transcripts readily detected comprise the latency-
associated transcripts (LATs) (reviewed by Efstathiou &
Preston, 2005; Wagner & Bloom, 1997). The LATs are
encoded within the repeats flanking the unique-long region
of the virus genome. The primary 8.3 kb LAT transcript
termed minor LAT is present in low abundance and is
processed to yield two stable introns of 1.5 and 2 kb in
addition to at least eight micro (mi)RNAs (Jurak et al., 2010;
Umbach et al., 2008, 2009, 2010). The HSV-encoded LATs
have multiple functions. Mutants deficient for LAT expres-
sion result in increased neuronal death (Thompson &
Sawtell, 2001), apoptosis (Perng et al., 2000), enhanced
entry into lytic cycle (Chen et al., 1997; Garber et al., 1997)
and a reduction in the levels of heterochromatin markers
associated with the latent virus genome (Cliffe et al., 2009).
These data suggest that the major biological functions of
LATs are to promote neuronal survival at an early stage
following infection or during reactivation, to negatively
regulate viral gene expression via the formation of repressive
heterochromatin on lytic promoters and to downregulate
expression of viral immediate-early (IE) protein synthesis by
LAT-encoded micro RNAs. Such functions would serve to
stabilize latency and introduce important checkpoints in the
control of reactivation. In addition, there is accumulating
evidence from both experimental model systems and
examination of human trigeminal ganglia (TG), supportingSupplementary material is available with the online version of this paper.
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an important role for virus-specific CD8+ T-cells in the
surveillance of neurones within latently infected ganglia
(reviewed by Sheridan et al., 2007). Such virus-specific
CD8+ T-cells have been shown to rescue cells at early stages
of reactivation through non-cytolytic mechanisms involving
secretion of gamma interferon (Liu et al., 2000, 2001) and
inactivation of the essential IE ICP4 protein by CD8+ T-cell-
derived granzyme-B (Knickelbein et al., 2008). The net
outcome of such immunological control is a block in
progression of a full lytic cycle and stabilization of latency.
These data are inconsistent with a simple default model of
latency, which is centred on latency establishment being the
consequence of a failure of IE gene activation. We have
previously utilized a Cre reporter mouse model system to
perform a historical analysis of virus promoter activation in
the dorsal root ganglia (DRG) (Proenc¸a et al., 2008). In this
system, virus expressed Cre-recombinase induces a perman-
ent genetic modification in the host cell that results in
reporter gene activation. Therefore, if a cell survives to
become latently infected it will be marked for life and can be
easily identifiable. Using recombinant viruses expressing Cre-
recombinase under the control of latent and lytic cycle virus
promoters revealed that IE ICP0 promoter (ICP0P) activity
could precede latency establishment in approximately 1/3 of
the total latent reservoir. IE promoter activation is mediated
by the virion transactivator VP16, which although consid-
ered a leaky-late (L1) gene (Lieu & Wagner, 2000) has
recently been shown to be differentially regulated in neurones
and to play a central role in the initiation of hyperthermic
stress-induced virus reactivation (Thompson et al., 2009). In
this paper, we have sought to determine whether VP16
promoter (VP16P) activation can precede latency establish-
ment and therefore provide a mechanistic basis for the
observed activation of the ICP0P prior to latency establish-
ment. Using recombinant viruses encoding Cre-recombinase
under the control of the L1 VP16 or early (E) thymidine
kinase (TK) promoters, we show that infection of reporter
mice with these viruses results in inefficient cell marking and
consequent neuronal reporter gene expression during
latency. These data are consistent with the view that
expression of these representative E and L1 gene products
is largely incompatible with cell survival and establishment of
latency. In contrast, infection of reporter mice expressing
Cre-recombinase under ICP0 or ICP4 IE promoter control
results in high frequency cell marking that is maintained
during latency. We conclude that a significant proportion of
the latent cell reservoir experience VP16-independent IE
promoter activation prior to the establishment of latency.
RESULTS
In vitro and in vivo characterization of HSV-1-
based recombinants encoding Cre-recombinase
Viruses expressing Cre-recombinase under IE ICP4, E TK
or L1 VP16P control were constructed on the HSV-1 strain
SC16 background as described in Methods. The genomic
structures of all recombinant viruses were confirmed by
restriction enzyme digestion and Southern blot hybridiza-
tion analyses (data not shown). Schematic representations
of the ROSA26 locus in the ROSA26 reporter (R26R)
animals and recombinant virus structures are shown in Fig.
1(a, b). All recombinants replicated with wild-type (WT)
kinetics in vitro (Fig. 1c). Acute phase replication in the
ears and CII, CIII and CIV sensory ganglia of mice revealed
no obvious growth deficit of recombinants in comparison
to WT SC16 (Fig. 1d). Real-time PCR-based quantification
of latent DNA loads in sensory ganglia revealed that all
recombinants established latency to WT levels (Fig. 1e).
These data indicate that the recombinants are phenotypi-
cally indistinguishable from WT virus in vivo and are
consistent with previous observations concerning the lack
of detectable phenotypes of viruses carrying gene insertions
in the Us5 locus (Balan et al., 1994; Proenc¸a et al., 2008;
Thompson et al., 2003).
ICP4 promoter activation is compatible with
latency establishment in a subpopulation of
infected neurones
Previous studies have shown that infection of R26R mice
with HSV-1 recombinants expressing Cre-recombinase
under the control of the human cytomegalovirus
(HCMV) major (M) IE or LAT promoters results in
efficient reporter gene activation and marking of latently
infected neurones (Proenc¸a et al., 2008; Wakim et al.,
2008). The observation that Cre-recombinase expressed
from the IE ICP0, but not the true late (L2) glycoprotein
(g)C promoter, results in marking of approximately 1/3 of
the total latent cell reservoir indicates that a significant
proportion of infected cells experience ICP0P activity prior
to the establishment of latency (Proenc¸a et al., 2008). In
order to determine whether activation of the ICP0P prior
to latency establishment is a specific property of this IE
promoter or a more general feature of HSV-1 IE promoters
we examined the properties of the IE ICP4 promoter
(ICP4P). A recombinant virus containing the ICP4P linked
to Cre-recombinase (HSVICP4Cre) was constructed and
used to infect R26R mice. CII, CIII and CIV DRGs were
pooled from five mice at 5 and 30 days post-infection
(p.i.), X-Gal stained and then imaged. At day 5 p.i., a mean
(±SEM) of 52.6±11.6 beta-galactosidase (b-Gal)-positive
cells per ganglion was detected, whereas a mean of
38.2±5.8 positive cells per ganglion was detected at
30 days p.i., a time consistent with the establishment of
latency (Fig. 2a). This indicates that both IE ICP0 and
ICP4P have the capacity for transient activity prior to the
establishment of latency.
Activation of the E TK promoter is largely
incompatible with latency establishment
Having established that IE ICP4P activity can be compat-
ible with cell survival and latency establishment, we next
sought to determine whether the detection of marked cells
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Fig. 1. (a) Structure of the ROSA26 locus in R26R reporter mice. The transgene contains a splice acceptor sequence (SA)
upstream of a neomycin phosphotransferase gene (neo) flanked by loxP sites and downstream of a lacZ gene. Following Cre
recombination, the neo gene is removed and the lacZ gene is constitutively expressed by the ROSA26 promoter (Soriano,
1999). (b) Genomic structures of Cre-expressing viruses: HSVICP4Cre, HSVTKCre and HSVVP16Cre have a Cre expression
cassette inserted in the non-essential Us5 region. This cassette contains the promoter of interest upstream of Cre-
recombinase. The Cre gene is fused to a nuclear localization signal and contains an intron 578 bp downstream of the
transcription start site. (c) In vitro growth curves of recombinants and WT strain SC16 are from a single experiment performed
in BHK cells. (d) In vivo pathogenicity studies. Virus titres in ears and pooled CII, CIII and CIV ganglia of BALB/c (HSVTKCre) or
C57B6 (HSVICP4Cre/VP16Cre) mice sampled at day 5 p.i. Data points represent mean viral titres from five mice±SEM for
each recombinant and WT strain SC16. Each panel represents an independent experiment. (e) Latent DNA loads of
recombinant viruses. Real-time PCR was performed on DNA extracted from latently infected ganglia (CII, CIII and CIV pooled
from five mice) using as targets ICP0 and APRT. Values represent the mean±SEM of the numbers of the HSV genome copies
per 104 copies of APRT from triplicate PCRs.
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during latency would be a feature of the representative E
TK promoter (TKP).
R26R mice were infected with HSVTKCre and killed at
days 5 (n55), 31 (n54) and 60 (n55) p.i. and the CII, CIII
and CIV DRG were dissected and X-Gal stained prior to
imaging. The numbers of marked cells per ganglion are
plotted in Fig. 2(b). At day 5 p.i. infection, a mean (±SEM)
of 18.5±4 positive cells per ganglion was detected. This
represents a three- to fourfold decrease in the numbers of
cells marked by recombinant viruses encoding Cre-
recombinase under IE promoter control. Although all the
Cre-expressing recombinants have WT replication kinetics
both in vitro and in vivo, the number of cells marked
during the acute phase of infection in vivo vary depending
on the particular recombinant under investigation. The
observed variation in the number of marked cells during
acute infection is heavily influenced by the kinetic class of
promoter used to drive Cre expression. Thus, in earlier
studies (Proenc¸a et al., 2008) we have shown that
expression of Cre-recombinase under the control of the
L2 gC promoter is unable to efficiently mediate lacZ
expression in vitro following infection of a reporter cell line
and similarly resulted in the inefficient labelling of cells in
mouse DRGs during acute infection. This is despite the fact
that this recombinant exhibited WT growth kinetics both
in vitro and in vivo.
In the context of lytic infection, timing of Cre expression
appears to significantly influence the efficiency of cell
marking. We consider it highly probable that placing Cre-
recombinase under either E or late (L) promoter control
results in inefficient Cre-mediated lacZ expression during
lytic infection as a consequence of virus-induced cytopathic
effects severely restricting host-cell gene expression. Under
these circumstances Cre-mediated cell marking will under-
represent the true numbers of virus-infected cells.
During latency a mean (±SEM) of 3.9±0.7 and 3.1±0.6
marked cells was detected at days 31 and 60 p.i. with
HSVTKCre, respectively (Fig. 2b). Statistically the marked
cell counts recorded at the latent time points are not
significantly different from each other (P50.54). However,
the drop in the number of marked cells between day 5 and
each of the latent time points is statistically significant
(P50.036, day 31 and P50.006, day 60). We interpret this
decrease in cell marking to represent the death and loss of
productively infected cells during the acute stage of
infection.
The stable, low level of cell marking observed with the early
TKP during latency at days 31 and 60 p.i. is similar to that
observed previously with the L2 gC promoter. Thus, gC
promoter driven Cre expression resulted in a mean (±SEM)
of 1.9±0.35 and 2±0.36 b-Gal-positive neurones per
ganglion at 30 and 124 days p.i., respectively (Proenc¸a et al.,
2008). Whether these marked cells represent neurones
that have survived E or L2 HSV promoter activity during
the establishment of latency or are the products of abortive
reactivation events is currently unknown. However, in
comparison to the high frequency of cell marking observed
during latency with HSV recombinants expressing Cre-
recombinase under the control of IE or LAT promoters
(Fig. 2a and Proenc¸a et al., 2008), we conclude that E and L
HSV-1 promoter activation is largely incompatible with cell
survival and the establishment of latency.
Activation of the VP16P is incompatible with
latency establishment
Recently, the classically defined L1 VP16P has been shown
to exhibit distinct regulation in neurones, which is
functionally important both for acute phase lytic neuronal
infection and the earliest stages of reactivation from latency
(Thompson et al., 2009). Given that HSV-1 IE gene
activation of non-neuronal cells is principally depend-
ent on VP16/Oct-1/HCF complex recognition of IE
TAATGARAT motifs (Kristie & Roizman, 1987; Preston
et al., 1988; Stern et al., 1989) raises the question of
whether the marking of latently infected neurones observed
by the IE ICP0 and ICP4P driven Cre constructs is
dependent on de novo VP16 expression. In this scenario,
VP16P activation during latency establishment would be
compatible with cell survival in the population of neurones
Fig. 2. In vivo reporter gene expression activated by HSVICP4Cre
and HSVTKCre. Number of positive cells per ganglion detected at
the specified time points p.i. of R26R mice with HSVICP4Cre (a)
and HSVTKCre (b). Each symbol represents an individual ganglion
and the bar represents the mean at the given time point.
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that have been shown to tolerate prior IE promoter
activation. With the aim of testing this hypothesis an
HSV-1 recombinant encoding Cre-recombinase under the
control of the VP16P was constructed and used to infect
R26R mice. At days 5 (n54) and 44 (n54) p.i., CII, CIII and
CIV DRGs were stained with X-Gal and the number of b-
Gal-positive cells enumerated (Fig. 3a). At day 5 p.i., a mean
(±SEM) of 14±5.2 b-Gal-positive cells per ganglion was
detected. This low level of cell marking is similar to what we
have observed for the TK and gC promoters and therefore
appears to be a characteristic feature of promoters exhibiting
conventional E and/or L kinetics. By day 44 p.i., the numbers
of marked cells detected were significantly lower than at
the acute time point and decreased to a mean (±SEM) of
1.1±0.3 positive cells per ganglion (P50.019). The
frequency of marked cells during latency was therefore
similar to that observed with the gC and TKPs (Fig. 2b and
Proenc¸a et al., 2008) and in comparison to IE promoter
driven Cre constructs we observed a .10-fold decrease in
numbers of marked cells identified during latency.
For a more accurate comparison of the frequency of cell
marking by virus recombinants encoding Cre-recombinase
under either VP16, ICP0 or ICP4P control, R26R mice
Fig. 3. In vivo reporter gene expression activated by HSVVP16Cre. (a) Number of positive cells per ganglion detected at the
specified time points p.i. of R26R mice with HSVVP16Cre. (b) Light micrographs of X-Gal stained DRG from R26R mice
infected with HSVICP0Cre, HSVICP4Cre and HSVVP16Cre at days 6 and 50 p.i. (c) Number of positive cells per ganglion
detected following infection of R26R mice with HSVICP0Cre, HSVICP4Cre and HSVVP16Cre at days 6 and 50 p.i. Each
symbol represents a ganglion and the bar represents the mean at the given time point.
HSV promoter activity compatible with latency
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were infected in parallel with HSVVP16Cre, HSVICP0Cre
and HSVICP4Cre. At day 6 p.i., the mean number of b-Gal-
positive cells (±SEM) detected in CII, CIII and CIV DRG
were: 66±9.1, 21±4.7 and 10±2 positive cells per ganglion
for ICP0, ICP4 and VP16P driven Cre constructs, respect-
ively. At the latent time point, 50 days p.i., the mean number
of b-Gal-positive cells (±SEM) detected was 60±7, 27±5
and 1.4±0.32 positive cells per ganglion for the ICP0, ICP4
and VP16P driven Cre constructs, respectively (Fig. 3b, c).
Therefore, cell marking of latently infected neurones
mediated by IE promoter activation appears to occur in a
manner that is not dependent on prior VP16P activation.
Since previous reports have highlighted differences in the
behaviour of HSV-1 in murine DRG versus TG (Sawtell &
Thompson, 1992), we next examined the possibility that
such anatomical differences could impact on HSV-1-
mediated cell marking in the R26R model system. In order
to target the TG, reporter animals were infected by
scarification of the whisker pad. At 5 and 33 days p.i., TG
ganglia were X-Gal stained and imaged (data not shown and
Fig. 4a). At day 5 p.i., a mean (±SEM) of 577±287,
187±152 and 9±5 b-Gal-positive cells per TG ganglion
was detected following infection with HSVCMVCre,
HSVICP0Cre and HSVVP16Cre, respectively. At the latent
time point, 33 days p.i., a mean (±SEM) of 570±68,
136±76 and 2±2.7 b-Gal-positive cells per ganglion was
detected for HCMV MIE, ICP0 and VP16P driven Cre
constructs, respectively (Fig. 4a, b).
From the data accumulated from both the ear pinna and
whisker pad infection models that target DRG and TG,
respectively, we conclude that as for the TK and gC
promoters expression of Cre-recombinase from the L1
VP16P is largely incompatible with cell survival and latency
establishment. Therefore, HSV-1 IE promoter activation
leading to the marking of latently infected sensory neurones
is likely to occur through a VP16-independent mechanism.
VP16-independent activation of the ICP0 and ICP4
promoters in primary neuronal cultures
Our studies using reporter mice suggest that marking of
latently infected neurones by virus recombinants encoding
Cre-recombinase under IE promoter control is likely to
reflect neuronal-specific activity of these promoters. In order
to examine the potential of these promoters to be activated in
neurones in the absence of VP16 we examined the properties
of VP16 transactivation-deficient mutants in primary
neuronal cultures. DRG cultures were prepared from
neonatal rats as described in Arthur et al. (2001). All
recombinant viruses were based on HSV-1 strain 17 in1814
mutant that has a 12 bp insertion within the VP16-coding
sequences (Ace et al., 1989). As a consequence of this
mutation, in1814 exhibits a severe deficit for VP16-mediated
IE promoter activation. In order to investigate the VP16
dependence of ICP0P activation following infection of
primary neurones we utilized two previously described
replication defective virus mutants designated in1383 and
in1380, which contain an ICP0P lacZ reporter cassette
inserted in the TK locus. in1383 has the VP16 mutation of
in1814, a deletion of the essential ring domain of ICP0 and a
temperature-sensitive mutation of ICP4 that inactivates this
Fig. 4. In vivo reporter gene expression activated by HSVCMVCre, HSVICP0Cre and HSVVP16Cre in the TG of R26R reporter
animals. (a) Light micrographs of representative TG infected with HSVCMVCre, HSVICP0Cre and HSVVP16Cre at 33 days
p.i. (b) Number of positive cells per TG detected following infection of R26R mice with HSVCMVCre, HSVICP0Cre and
HSVVP16Cre at days 5 and 33 p.i. Each symbol represents a TG and the bar represents the mean at the given time point.
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essential regulatory protein at temperatures.38 uC (Preston
et al., 1997). in1380 is a VP16 rescuant of in1383 (Fig. 5a).
Primary neuronal cultures seeded at a density of 800–1000
neurones per well were infected with either VP16+ (in1380)
or VP162 (in1383) mutants at 105 p.f.u. per well. We
estimate that the number of non-neuronal cells per well
exceeds the number of neurones plated by a factor of five
therefore the theoretical m.o.i. at 105 p.f.u. is approximately
20 p.f.u. per cell. Cultures infected with in1380 or in1383
analysed 2 days p.i., resulted in readily detectable ICP0P
driven b-Gal expression in 79 and 51% of b-tubulin III-
positive cells, respectively (Fig. 5). Analyses of viral genome
loads revealed that in this experiment cultures infected with
in1383 had received 1.76108 genomes per well, whereas
cultures infected with in1380 had received 1.16109 genomes
per well (Fig. 5c). Therefore, even following infection with
approximately 6.5-fold fewer input genomes VP16-independ-
ent activation of the ICP0P was evident in greater than 50%
of neurones. Increasing the in1383 virus input to 56105 p.f.u.
per well (8.56108 input genomes) resulted in b-Gal
expression in 75% of neurones. From these data, we conclude
that there is no absolute requirement for VP16-mediated
ICP0P activation in cultured sensory neurones and that the
efficiency of activation of this promoter is input dose
dependent. In contrast, ICP0P activation in b-tubulin III-
negative non-neuronal cells, showed a strong VP16 depend-
ence. Thus, following infection of cultures with the VP16-
deficient mutant in1383 at 56105 p.f.u., b-Gal expression was
detected in 39% of non-neuronal cells, whereas infection of
cultures with an equivalent input of the VP16 rescuant virus
(in1380) resulted in ICP0P driven b-Gal expression in 89% of
b-tubulin III-negative non-neuronal cells (data not shown).
In order to determine whether the VP16-independent
activation of IE ICP0P activity in neurones was a specific
feature of this promoter we next examined the properties
of the ICP4P. Infection of neuronal cultures with 56105
p.f.u. (1.36108 input genomes) per well of the VP16-
mutant (in1329), containing an ICP4P lacZ reporter
cassette in the TK locus (Homer et al., 1999), resulted in
b-Gal expression in 32% of neurones and no detectable
reporter gene expression in non-neuronal cells. Although,
the level of b-Gal expression was notably weaker for the
ICP4P than that observed for the ICP0P examined in the
context of in1383, it appears that at least for the two IE
promoters selected for the assay, there appears to be no
absolute requirement for VP16 for their activity in cultured
sensory neurones. These in vitro data, in conjunction with
our observations using reporter mice infected with viruses
encoding Cre-recombinase under IE or VP16P control
indicate the existence of VP16-independent mechanisms of
IE promoter activation in sensory neurones.
DISCUSSION
In this study, we have analysed the extent of viral promoter
activation compatible with latency establishment using a
Fig. 5. Activation of the ICP0 and ICP4Ps in primary neuronal cultures. (a) Genomic structures of in1380, in1383 and in1329.
(b) Representative immunofluorescent images of neuronal cultures infected with 105 p.f.u. of in1380 and in1383 and 5105
p.f.u. of in1329. Cultures were fixed 2 days p.i. and immunostained for expression of b-Gal (FITC, green) and neurone-specific
b-tubulin III (Cy3, red) and counterstained with DAPI to show cell nuclei (blue). The merged images show co-visualization of
FITC, Cy3 and DAPI fluorescence in which co-localization of b-Gal and b-tubulin III gives a yellow–orange signal. (c) Summary
histogram showing the percentage of b-Gal-positive neurones detected 2 days following infection with in1380, in1383 and
in1329. The infection dose in terms of p.f.u. or genome load per well is indicated.
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previously described Cre reporter mouse system (Proenc¸a
et al., 2008; Wakim et al., 2008). The system involves the
infection of R26R reporter mice with HSV-1 recombinants
engineered to express Cre-recombinase under the control
of representative IE, E or L virus promoters. In the event of
promoter activation, associated with cell survival and the
establishment of latency, Cre expression induces a
permanent genetic change in the host cell resulting in
reporter gene expression and cell marking.
Using this system, we show that IE ICP4P driven Cre
expression results in the marking of ganglionic cells during
acute and latent infection in a pattern similar to that
previously described for the IE ICP0P (Proenc¸a et al.,
2008). In a direct comparison, 66±9.1 and 21±4.7
positive cells per ganglion were detected 6 days after ear
pinna infection with HSVICP0Cre and ICP4Cre recombi-
nants, respectively. Examination of latently infected
sensory ganglia 50 days p.i. revealed 60±7 and 27±5
positive cells per ganglion for the HSVICP0Cre and
ICP4Cre recombinants, respectively. There is no significant
difference between the numbers of marked cells detected at
days 6 and 50 for either virus (P.0.3). However, when
comparing the numbers of marked cell achieved at days 6
or 50 between the two viruses the differences are highly
significant (P,0.0009) with higher frequency of marking
achieved by the ICP0Cre recombinant at both acute
and latent time points. Given that HSV IE promoters are
largely silenced during latency we conclude that both IE
promoters exhibit activity prior to latency establishment,
but do so with differing efficiency. The difference in cell
marking achieved by the two recombinants is unlikely to be
due to different viral replication kinetics since both viruses
replicate in a manner indistinguishable to WT strain SC16
in vivo, and establish normal latent DNA loads. Since Cre-
mediated recombination is a stochastic event, the efficiency
of which is influenced by the level and duration of
recombinase expression (Nagy, 2000), it seems likely that
the different levels of cell marking observed for the IE ICP0
and ICP4P reflect the relative strength of these promoters
in neurones. In support of this view, investigation of the
activity of the ICP0 and ICP4P in the context of replication
defective vectors lacking the transactivating function of
VP16, revealed enhanced intensity of reporter gene
expression and higher numbers of neurones expressing b-
Gal driven from the ICP0 versus the ICP4P. Thus, infection
of primary neurones with in1383 (ICP0-lacZ) resulted in
strong b-Gal expression in 51% of neurones, whereas
in1329 (ICP4-LacZ) resulted in lower levels of reporter
gene expression in 32% of neurones. Our experiments with
Cre reporter animals reveal a similar disparity in the
efficiency of cell marking with the ICP0P, resulting in Cre-
mediated reporter gene activation in over twice as many
neurones as the ICP4P.
In contrast to the data obtained with recombinant viruses
expressing Cre under IE promoter control a recombinant
engineered to express Cre under the control of the E TKP
did not mark significant numbers of neurones (Fig. 2a).
The frequency of cell marking was similar to that
previously described for the L2 gC promoter (Proenc¸a
et al., 2008). Of particular interest was the observation that
HSVVP16Cre behaved in a similar fashion to the TK and
gC Cre recombinants. Thus, recombinant viruses expres-
sing Cre-recombinase from either E, L1 and L2 promoters
resulted in inefficient cell marking during acute infection
and resulted in less than four marked neurones per
ganglion during latency. As summarized in Fig. 6, a similar
pattern of cell marking was observed both in DRG and TG
neurones, indicating that virus promoter activation is not
significantly influenced by either ganglionic type or
anatomical site of infection.
De novo expression of VP16 at early times following
neuronal infection has been shown to be critical for entry
into lytic cycle (Thompson et al., 2009) and would be
consistent with the observed low frequency of cell marking
by the HSVVP16Cre recombinant during latency. Thus,
neurones exhibiting VP16P activity would initiate the lytic
programme of gene expression and enter the productive
cycle, which would result in cell death. Less clear is the
inability of the reporter mouse system to reveal VP16P Cre
marked cells at early times following acute infection. An
expectation of neuronal-specific de novo activation of the
VP16P is that it would express Cre-recombinase with
similar kinetics to the IE ICP0 and ICP4P and therefore
Fig. 6. Relative numbers of marked cells detected during latency
following infection with the specified Cre-expressing HSV
recombinants in DRG (a) and TG (b) of R26R reporter animals.
J. T. Proenc¸a and others
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result in efficient cell marking during acute ganglionic
infection.
By comparison of the numbers of marked cells generated
by the IE promoters and the VP16P we conclude that IE
promoter activation compatible with neuronal cell survival
and latency establishment is likely to be independent of de
novo synthesis of VP16. It has previously been shown that
VP16 is not required for latency establishment in vivo
(Ecob-Prince et al., 1993; Marshall et al., 2000; Steiner
et al., 1990). In contrast, de novo synthesis of VP16 has a
key role in the initiation of virus gene expression in
neurones. Thus, neuronal-specific activation of VP16
during acute infection and hyperthermia-induced react-
ivation is associated with lytic cycle entry and productive
cycle replication (Thompson et al., 2009), events that
would preclude survival of neurones experiencing VP16P
activation. Our inability to efficiently mark latently
infected neurones with HSVVP16Cre is therefore consist-
ent with the view that de novo activation of the VP16P is
incompatible with cell survival and latency.
At present, we cannot formally exclude the possibility that
our inability to detect efficient cell marking during acute
ganglionic infection with the VP16 Cre recombinant is a
consequence of transient low level de novo expression of
Cre-recombinase from this promoter, resulting in inef-
ficient loxP-mediated recombination and reporter gene
activation. However, our studies using a primary neuronal
cell culture system have revealed that IE ICP0 and ICP4P
activation in neurones can occur in the absence of
functional VP16. It should, however, be noted that these
in vitro experiments were performed at high multiplicities
of infection and high virus DNA input loads. We therefore
cannot formally exclude the possibility that the VP16
requirement for IE promoter activation might be greater in
neurones at low multiplicities of infection. Nonetheless,
our results are consistent with studies using reporter
transgenic mice that have shown expression of reporter
genes in trigeminal neurones linked to the IE ICP0 and
ICP4P, but not the ETK or L2 gC promoters (Loiacono
et al., 2002, 2003, 2004). Together these data are strongly
supportive of the view that HSV IE promoters and in
particular the ICP0P can be targeted for activation in
sensory neurones via the action of cellular factors.
The biological significance of the population of neurones
marked as a consequence of ICP0 or ICP4P activity is
unclear. At present, we do not know whether the promoter
activity mediating cell marking is indicative of IE protein
expression. In the case of ICP0, previous studies have
reported the detection of low levels of largely unspliced
ICP0 transcripts during latency (Chen et al., 2002; Maillet
et al., 2006; Thompson & Sawtell, 2006), suggesting that
transcriptional activity is unlikely to result in functional
ICP0 protein expression and may reflect a splicing related
mechanism of latency maintenance. Of possible signific-
ance are the small but highly reproducible numbers of
neurones that have experienced and survived E and/or L
promoter activation. Given that only a small proportion of
cells amongst the pool of latently infected neurones are
known to respond to either in vivo or ex vivo reactivation
stimuli it will be of particular interest to examine these
subsets of cells and determine whether they represent a
reactivation primed population of neurones.
METHODS
Cells and viruses. All recombinant viruses were derived from HSV-1
strains SC16 (Hill et al., 1975) and 17syn+ (Brown et al., 1973).
Viruses were propagated and assayed on BHK cells unless stated
otherwise. Cells were grown in Glasgow’s modified Eagles medium
supplemented with 10% FCS and 10% tryptose phosphate broth.
SUA cells are a Vero-derived cell line containing a loxP-flanked
cassette between the CAG promoter and reporter gene. Cre-
recombinase mediates removal of the loxP-flanked cassette and
expression of lacZ (Rinaldi et al., 1999).
The replication defective viruses used for infection of primary
neuronal cultures have been described previously (Homer et al., 1999;
Marshall et al., 2000; Preston et al., 1997).
Plasmids. All Cre-expressing plasmids were tested in SUA Cre
reporter cells by transfection. The construction of all plasmids is
described in the Supplementary Methods (available in JGV Online).
Construction of recombinant viruses. BE8 is an HSV-1 strain
SC16 recombinant containing a CMV promoter lacZ cassette inserted
into the non-essential Us5 locus.
HSVTKCre was constructed by co-transfection of pHD5-TKCre
linearized with ScaI and BE8-infected cell DNA. HSVTKCre contains
the TK Cre-recombinase cassette inserted into Us5 locus at the SstI
restriction site at genomic coordinate 137946. The ability of the
recombinant to express functional Cre-recombinase was confirmed in
SUA cells (data not shown).
HSVVP16Cre was generated by co-transfection of PstI linearized
pHD5-VP16Cre and BE8-infected cell DNA placing the Cre-
recombinase gene under VP16P control at the non-essential Us5
locus. Cre expression was confirmed by RT real-time PCR (data not
shown).
HSVICP4Cre was constructed by co-transfection of PstI linearized
pHD5-ICP4Cre and BE8-infected cell DNA placing the Cre-
recombinase gene under ICP4P control at the non-essential Us5
locus. Cre expression was confirmed by infection of SUA Cre reporter
cell line (data not shown).
Three days post-transfection, infected BHK cell monolayers were
harvested, sonicated and recombinant progeny were selected based on
failure to stain positive for b-Gal (HSVTKCre, HSVICP4Cre and
HSVVP16Cre) due to replacement of the lacZ expression cassette in
the parental virus BE8. Viral genomic structures (Fig. 1) were
confirmed by restriction endonuclease digestion and Southern blot
hybridization analyses (data not shown).
In vitro growth curves. In vitro assays were performed as described
previously (Proenc¸a et al., 2008).
In vivo assays. In vivo replication assays were performed using 7- to
8-week-old female BALB/c or C57B6 mice as described previously
(Proenc¸a et al., 2008).
R26R reporter mice (Soriano, 1999) were used for the in vivo
characterization of HSV recombinants encoding Cre-recombinase.
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Groups of adult mice (.8 weeks of age) that differed in age by less
than 12 days were infected with 106 or 26106 p.f.u. of virus by
scarification of the left ear, both ears or both whisker pads. Animal
gender was matched per experiment or in the case of experiments
including more than one virus, matched per time point. At various
times p.i., mice were killed and CII, CIII and CIV cervical ganglia or
both TGs were pooled, fixed on ice for 1 h in 4% paraformaldehyde
and stained histochemically for X-Gal as described previously
(Lachmann & Efstathiou, 1997).
DNA extraction for quantitative real-time PCR. DNA extractions
were performed as described previously (Coleman et al., 2008;
Proenc¸a et al., 2008).
Statistical analysis. Statistical differences between the numbers of
marked cells/sensory ganglia from mice sampled at different time
points were determined by the Mann–Whitney test.
Primary neuronal cultures. Primary neuronal cell cultures were
prepared as described previously (Arthur et al., 2001).
Detection and quantification of reporter gene expression in
neuronal cultures. Neuronal cultures staining and imaging was
performed as described previously (Arthur et al., 2001).
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